CVS Health Corporation (CVS)
USD 45.28
(2.82%)
USD 45.28
(2.82%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 13.74 Billion USD | -10.6% |
| 2022 | 15.74 Billion USD | 19.32% |
| 2021 | 13.19 Billion USD | -5.16% |
| 2020 | 13.91 Billion USD | 16.05% |
| 2019 | 11.98 Billion USD | 198.11% |
| 2018 | 4.02 Billion USD | -57.75% |
| 2017 | 9.51 Billion USD | -7.94% |
| 2016 | 10.33 Billion USD | 9.35% |
| 2015 | 9.45 Billion USD | 7.44% |
| 2014 | 8.79 Billion USD | 9.48% |
| 2013 | 8.03 Billion USD | 11.19% |
| 2012 | 7.22 Billion USD | 14.19% |
| 2011 | 6.33 Billion USD | 2.68% |
| 2010 | 6.16 Billion USD | -4.24% |
| 2009 | 6.43 Billion USD | 6.48% |
| 2008 | 6.04 Billion USD | 26.14% |
| 2007 | 4.79 Billion USD | 96.32% |
| 2006 | 2.44 Billion USD | 20.9% |
| 2005 | 2.01 Billion USD | 38.83% |
| 2004 | 1.45 Billion USD | 325.72% |
| 2003 | 341.7 Million USD | -71.67% |
| 2002 | 1.2 Billion USD | 56.53% |
| 2001 | 770.6 Million USD | -41.74% |
| 2000 | 1.32 Billion USD | 16.49% |
| 1999 | 1.13 Billion USD | 22.03% |
| 1998 | 930.5 Million USD | 44.82% |
| 1997 | 642.5 Million USD | 114.45% |
| 1996 | 299.6 Million USD | 54.43% |
| 1995 | 194 Million USD | -68.23% |
| 1994 | 610.7 Million USD | -2.02% |
| 1993 | 623.3 Million USD | 72.71% |
| 1992 | 360.9 Million USD | -46.1% |
| 1991 | 669.6 Million USD | 0.81% |
| 1990 | 664.2 Million USD | 0.5% |
| 1989 | 660.9 Million USD | 12.09% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.23 Billion USD | 34.08% |
| 2024 Q1 | 1.87 Billion USD | -32.67% |
| 2023 FY | 14.07 Billion USD | -10.6% |
| 2023 Q2 | 3.61 Billion USD | 2.38% |
| 2023 Q4 | 3.43 Billion USD | -2.27% |
| 2023 Q1 | 3.52 Billion USD | -5.52% |
| 2023 Q3 | 3.51 Billion USD | -2.63% |
| 2022 Q2 | 4.52 Billion USD | 15.94% |
| 2022 Q1 | 3.9 Billion USD | 75.06% |
| 2022 FY | 15.74 Billion USD | 19.32% |
| 2022 Q4 | 3.73 Billion USD | 4.3% |
| 2022 Q3 | 3.58 Billion USD | -20.84% |
| 2021 Q2 | 4.32 Billion USD | 20.94% |
| 2021 Q3 | 3.06 Billion USD | -29.24% |
| 2021 Q4 | 2.22 Billion USD | -27.18% |
| 2021 FY | 13.19 Billion USD | -5.16% |
| 2021 Q1 | 3.57 Billion USD | 41.72% |
| 2020 Q1 | 3.45 Billion USD | 13.86% |
| 2020 Q4 | 2.52 Billion USD | -22.31% |
| 2020 Q3 | 3.24 Billion USD | -30.58% |
| 2020 FY | 13.91 Billion USD | 16.05% |
| 2020 Q2 | 4.68 Billion USD | 35.34% |
| 2019 Q2 | 3.33 Billion USD | 23.87% |
| 2019 Q4 | 3.03 Billion USD | 3.72% |
| 2019 Q1 | 2.69 Billion USD | 226.46% |
| 2019 FY | 11.98 Billion USD | 198.11% |
| 2019 Q3 | 2.92 Billion USD | -12.12% |
| 2018 Q4 | 824 Million USD | -64.98% |
| 2018 FY | 4.02 Billion USD | -57.75% |
| 2018 Q3 | 2.35 Billion USD | 248.27% |
| 2018 Q1 | 1.94 Billion USD | -37.39% |
| 2018 Q2 | -1.58 Billion USD | -181.55% |
| 2017 Q2 | 2.11 Billion USD | 18.07% |
| 2017 Q4 | 3.1 Billion USD | 24.37% |
| 2017 Q1 | 1.79 Billion USD | -40.13% |
| 2017 FY | 9.51 Billion USD | -7.94% |
| 2017 Q3 | 2.49 Billion USD | 18.04% |
| 2016 Q3 | 2.81 Billion USD | 19.87% |
| 2016 Q1 | 2.17 Billion USD | -20.26% |
| 2016 Q2 | 2.35 Billion USD | 8.0% |
| 2016 Q4 | 2.99 Billion USD | 6.32% |
| 2016 FY | 10.33 Billion USD | 9.35% |
| 2015 FY | 9.45 Billion USD | 7.44% |
| 2015 Q2 | 2.26 Billion USD | 6.1% |
| 2015 Q1 | 2.13 Billion USD | -8.14% |
| 2015 Q4 | 2.72 Billion USD | 17.07% |
| 2015 Q3 | 2.33 Billion USD | 3.05% |
| 2014 Q3 | 2.24 Billion USD | 1.72% |
| 2014 FY | 8.79 Billion USD | 9.48% |
| 2014 Q4 | 2.32 Billion USD | 3.34% |
| 2014 Q1 | 2.02 Billion USD | -8.71% |
| 2014 Q2 | 2.2 Billion USD | 9.09% |
| 2013 Q4 | 2.21 Billion USD | 2.59% |
| 2013 FY | 8.03 Billion USD | 11.19% |
| 2013 Q1 | 1.69 Billion USD | -26.19% |
| 2013 Q2 | 1.96 Billion USD | 15.83% |
| 2013 Q3 | 2.16 Billion USD | 9.81% |
| 2012 Q3 | 1.81 Billion USD | 6.21% |
| 2012 Q1 | 1.4 Billion USD | -28.26% |
| 2012 FY | 7.22 Billion USD | 14.19% |
| 2012 Q4 | 2.3 Billion USD | 26.9% |
| 2012 Q2 | 1.7 Billion USD | 21.65% |
| 2011 Q3 | 1.58 Billion USD | 6.31% |
| 2011 Q1 | 1.31 Billion USD | -25.97% |
| 2011 FY | 6.33 Billion USD | 2.68% |
| 2011 Q4 | 1.95 Billion USD | 23.55% |
| 2011 Q2 | 1.49 Billion USD | 13.65% |
| 2010 Q4 | 1.77 Billion USD | 19.34% |
| 2010 FY | 6.16 Billion USD | -4.24% |
| 2010 Q1 | 1.41 Billion USD | -25.6% |
| 2010 Q2 | 1.5 Billion USD | 6.45% |
| 2010 Q3 | 1.48 Billion USD | -1.13% |
| 2009 Q4 | 1.89 Billion USD | 21.02% |
| 2009 FY | 6.43 Billion USD | 6.48% |
| 2009 Q3 | 1.56 Billion USD | -2.12% |
| 2009 Q2 | 1.59 Billion USD | 16.16% |
| 2009 Q1 | 1.37 Billion USD | -20.48% |
| 2008 Q2 | 1.47 Billion USD | 7.88% |
| 2008 Q3 | 1.46 Billion USD | -0.81% |
| 2008 FY | 6.04 Billion USD | 26.14% |
| 2008 Q4 | 1.73 Billion USD | 18.11% |
| 2008 Q1 | 1.37 Billion USD | -7.17% |
| 2007 Q2 | 1.3 Billion USD | 77.84% |
| 2007 Q1 | 736.5 Million USD | -1.71% |
| 2007 Q3 | 1.27 Billion USD | -2.95% |
| 2007 Q4 | 1.47 Billion USD | 16.11% |
| 2007 FY | 4.79 Billion USD | 96.32% |
| 2006 Q1 | 560.5 Million USD | -7.06% |
| 2006 Q4 | 749.3 Million USD | 39.59% |
| 2006 Q3 | 536.8 Million USD | -9.78% |
| 2006 Q2 | 595 Million USD | 6.16% |
| 2006 FY | 2.44 Billion USD | 20.9% |
| 2005 FY | 2.01 Billion USD | 38.83% |
| 2005 Q4 | 603.1 Million USD | 37.41% |
| 2005 Q3 | 438.9 Million USD | -8.12% |
| 2005 Q2 | 477.7 Million USD | -4.42% |
| 2005 Q1 | 499.8 Million USD | 44.49% |
| 2004 Q1 | 405.6 Million USD | 163.05% |
| 2004 Q2 | 387.2 Million USD | -4.54% |
| 2004 Q3 | 316 Million USD | -18.39% |
| 2004 Q4 | 345.9 Million USD | 9.46% |
| 2004 FY | 1.45 Billion USD | 325.72% |
| 2003 Q2 | 337 Million USD | 1.72% |
| 2003 Q4 | -643.3 Million USD | -303.13% |
| 2003 Q1 | 331.3 Million USD | -1.07% |
| 2003 FY | 341.7 Million USD | -71.67% |
| 2003 Q3 | 316.7 Million USD | -6.02% |
| 2002 Q1 | 296.5 Million USD | 271.39% |
| 2002 Q3 | 276.5 Million USD | -7.31% |
| 2002 Q2 | 298.3 Million USD | 0.61% |
| 2002 Q4 | 334.9 Million USD | 21.12% |
| 2002 FY | 1.2 Billion USD | 56.53% |
| 2001 Q3 | 220.2 Million USD | -35.61% |
| 2001 FY | 770.6 Million USD | -41.74% |
| 2001 Q4 | -173 Million USD | -178.56% |
| 2001 Q2 | 342 Million USD | -10.33% |
| 2001 Q1 | 381.4 Million USD | 3.3% |
| 2000 FY | 1.32 Billion USD | 16.49% |
| 2000 Q1 | 334.9 Million USD | 0.75% |
| 2000 Q3 | 284.7 Million USD | -14.73% |
| 2000 Q2 | 333.9 Million USD | -0.3% |
| 2000 Q4 | 369.2 Million USD | 29.68% |
| 1999 Q3 | 219.7 Million USD | -24.29% |
| 1999 FY | 1.13 Billion USD | 22.03% |
| 1999 Q4 | 332.4 Million USD | 51.3% |
| 1999 Q1 | 293.2 Million USD | 9.77% |
| 1999 Q2 | 290.2 Million USD | -1.02% |
| 1998 Q4 | 267.1 Million USD | 39.33% |
| 1998 Q2 | 232.9 Million USD | 5.1% |
| 1998 Q3 | 191.7 Million USD | -17.69% |
| 1998 Q1 | 221.6 Million USD | 9.11% |
| 1998 FY | 930.5 Million USD | 44.82% |
| 1997 Q1 | 94.6 Million USD | 6.05% |
| 1997 Q3 | 141.6 Million USD | 33.96% |
| 1997 Q4 | 203.1 Million USD | 43.43% |
| 1997 FY | 642.5 Million USD | 114.45% |
| 1997 Q2 | 105.7 Million USD | 11.73% |
| 1996 Q4 | 89.2 Million USD | 62.48% |
| 1996 Q2 | 84.2 Million USD | 200.71% |
| 1996 Q1 | 28 Million USD | -78.09% |
| 1996 FY | 299.6 Million USD | 54.43% |
| 1996 Q3 | 54.9 Million USD | -34.8% |
| 1995 Q1 | -35.2 Million USD | -108.55% |
| 1995 FY | 194 Million USD | -68.23% |
| 1995 Q2 | 81.5 Million USD | 331.53% |
| 1995 Q4 | 127.8 Million USD | 539.0% |
| 1995 Q3 | 20 Million USD | -75.46% |
| 1994 Q3 | 103.2 Million USD | 15.96% |
| 1994 Q4 | 411.7 Million USD | 298.93% |
| 1994 Q1 | 8.1 Million USD | -98.06% |
| 1994 FY | 610.7 Million USD | -2.02% |
| 1994 Q2 | 89 Million USD | 998.77% |
| 1993 FY | 623.3 Million USD | 72.71% |
| 1993 Q1 | -29.8 Million USD | -129.33% |
| 1993 Q3 | 88.1 Million USD | -39.74% |
| 1993 Q2 | 146.2 Million USD | 590.6% |
| 1993 Q4 | 418.6 Million USD | 375.14% |
| 1992 FY | 360.9 Million USD | -46.1% |
| 1992 Q1 | -9.4 Million USD | -102.17% |
| 1992 Q2 | 154.2 Million USD | 1740.43% |
| 1992 Q3 | 114.7 Million USD | -25.62% |
| 1992 Q4 | 101.6 Million USD | -11.42% |
| 1991 Q1 | 8 Million USD | -97.95% |
| 1991 Q2 | 116.7 Million USD | 1358.75% |
| 1991 Q3 | 112 Million USD | -4.03% |
| 1991 Q4 | 432.9 Million USD | 286.52% |
| 1991 FY | 669.6 Million USD | 0.81% |
| 1990 Q1 | 16 Million USD | -95.86% |
| 1990 Q4 | 390.6 Million USD | 232.14% |
| 1990 FY | 664.2 Million USD | 0.5% |
| 1990 Q3 | 117.6 Million USD | -15.76% |
| 1990 Q2 | 139.6 Million USD | 772.5% |
| 1989 FY | 660.9 Million USD | 12.09% |
| 1989 Q3 | 124.5 Million USD | 16.14% |
| 1989 Q2 | 107.2 Million USD | 152.83% |
| 1989 Q1 | 42.4 Million USD | 101.09% |
| 1989 Q4 | 386.8 Million USD | 210.68% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cigna Corporation | 8.53 Billion USD | -61.0% |
| Centene Corporation | 2.93 Billion USD | -369.044% |
| Elevance Health Inc. | 133.96 Billion USD | 89.741% |
| Humana Inc. | 4.01 Billion USD | -242.462% |
| Molina Healthcare, Inc. | 1.57 Billion USD | -773.681% |
| Oscar Health, Inc. | -235.61 Million USD | 5932.82% |
| UnitedHealth Group Incorporated | 32.35 Billion USD | 57.528% |